These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1619383)

  • 21. [Hemo-rheologic changes following treatment with human recombinant erythropoietin in chronic hemodialysis patients].
    Melappioni M; Giansanti R; Boemi M; Baldassari M; Baldini S; Pierangeli T; Radicioni R; Fumelli P; Panichi N
    Minerva Urol Nefrol; 1992; 44(2):155-9. PubMed ID: 1411865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin.
    Koppensteiner R; Stockenhuber F; Jahn C; Balcke P; Minar E; Ehringer H
    BMJ; 1990 Jun; 300(6740):1626-7. PubMed ID: 2372642
    [No Abstract]   [Full Text] [Related]  

  • 23. Rheological properties and membrane fluidity of red blood cells and platelets in primary hyperlipoproteinemia.
    Muller S; Ziegler O; Donner M; Drouin P; Stoltz JF
    Atherosclerosis; 1990 Aug; 83(2-3):231-7. PubMed ID: 2242099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
    de Sousa FT; Prata MM; Barbas JV; dos Santos JP
    Acta Med Port; 1990; 3(6):347-52. PubMed ID: 2089856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.
    Winearls CG; Oliver DO; Pippard MJ; Reid C; Downing MR; Cotes PM
    Lancet; 1986 Nov; 2(8517):1175-8. PubMed ID: 2877323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors evaluation in some cardiovascular diseases.
    Puniyani RR; Ajmani R; Kale PA
    J Biomed Eng; 1991 Sep; 13(5):441-3. PubMed ID: 1795515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered erythrocyte membrane protein composition in chronic kidney disease stage 5 patients under haemodialysis and recombinant human erythropoietin therapy.
    Costa E; Rocha S; Rocha-Pereira P; Castro E; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
    Blood Purif; 2008; 26(3):267-73. PubMed ID: 18417959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating haematopoietic progenitors during treatment of renal anaemia with recombinant human erythropoietin.
    Göbel V; Hoffmann HG; Müller-Wiefel DE; Braun A; Ludwig R; Schärer K; Debatin KM
    Eur J Pediatr; 1994 Jan; 153(1):43-8. PubMed ID: 8313924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does additional treatment with fish oil mitigate the side effects of recombinant human erythropoietin in dialysis patients?
    de Fijter CW; Popp-Snijders C; Oe LP; Tran DD; van der Meulen J; Donker AJ
    Haematologica; 1995; 80(4):332-4. PubMed ID: 7590502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoiesis and erythrocyte age distribution in hemodialysis patients undergoing erythropoietin therapy.
    Hampl H; Riedel E; Scigalla P; Stabell U; Wendel G
    Blood Purif; 1990; 8(3):117-25. PubMed ID: 2244989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blood fluidity in essential hypertension, arterial occlusive disease and diabetic angiopathies].
    Sternitzky R; Hänsgen K; Podhaisky H
    Z Gesamte Inn Med; 1991 Nov; 46(16):610-4. PubMed ID: 1792802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of normalization of hematocrit on brain circulation and metabolism in hemodialysis patients.
    Metry G; Wikström B; Valind S; Sandhagen B; Linde T; Beshara S; Långström B; Danielson BG
    J Am Soc Nephrol; 1999 Apr; 10(4):854-63. PubMed ID: 10203371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of recombinant human erythropoietin responsiveness by measuring erythrocyte creatine content in haemodialysis patients.
    Hasegawa S; Nakamura S; Sugiura T; Tsuka Y; Takahashi N; Matsumura K; Okumiya T; Baden M; Shiojima I
    BMC Nephrol; 2021 Dec; 22(1):413. PubMed ID: 34895154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
    Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
    Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of anaemia resistant to conventional erythropoietin therapy with thymopentin in haemodialysis patients.
    Raiola P; Manzo M; Saggese A; Tomasino G; Cicchella T; Rambaldi M; Pisano M; Lizza B; Perna AF
    Nephrol Dial Transplant; 1995; 10 Suppl 6():48-50. PubMed ID: 8524495
    [No Abstract]   [Full Text] [Related]  

  • 37. Rheological properties of erythrocytes in recombinant human erythropoietin-administered normal rat.
    Maeda N; Kon K; Tateishi N; Suzuki Y; Sekiya M; Taniguchi T; Seike M; Nakajima T; Shiga T; Tanaka K
    Br J Haematol; 1989 Sep; 73(1):105-11. PubMed ID: 2803965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Age and whole blood viscoelasticity. A risk factor study].
    Oder W; Kollegger H; Baumgartner C; Zeiler K; Oder B; Deecke L
    Acta Med Austriaca; 1991; 18 Suppl 1():71-4. PubMed ID: 1950394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folic acid supplementation improves erythropoietin response.
    Pronai W; Riegler-Keil M; Silberbauer K; Stockenhuber F
    Nephron; 1995; 71(4):395-400. PubMed ID: 8587618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of erythropoietin therapy and withdrawal on blood coagulation and fibrinolysis in hemodialysis patients.
    Taylor JE; Belch JJ; McLaren M; Henderson IS; Stewart WK
    Kidney Int; 1993 Jul; 44(1):182-90. PubMed ID: 8355460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.